3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
17
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
10
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Toxemia
1
Prostatic Neoplasms
1
Primary Ovarian Insufficiency
1
Polycystic Ovary Syndrome
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Diabetes, Gestational
1
Cardiovascular Diseases
1
Carcinoma
1
Breast Neoplasms, Male
1
Brain Neoplasms
1
Interventions
Docetaxel
17
Surveys and Questionnaires
15
pembrolizumab
14
Specimen Handling
10
Radiotherapy
10
Early Intervention, Educational
10
Zoledronic Acid
9
Interviews as Topic
9
olaparib
8
Standard of Care
8
Psychiatric Rehabilitation
8
Therapeutics
7
Magnetic Resonance Spectroscopy
7
Gemcitabine
7
Fulvestrant
7
durvalumab
6
Paclitaxel
6
Nivolumab
6
Methods
6
Educational Status
6
Carboplatin
6
enzalutamide
5
Trastuzumab
5
Radiosurgery
5
Exercise
5
Cyclophosphamide
5
palbociclib
4
Taxes
4
Sirolimus
4
Letrozole
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Positron-Emission Tomography
×
Breast
×
Clear all
NCT02437539
2015-08-24
uPAR-PET
Rigshospitalet, Denmark
Phase 1
Completed
10 enrolled